Replies to Post #1174 onEnanta Pharmaceuticals Inc (ENTA)

Replies to post #1174 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1174 on Enanta Pharmaceuticals Inc (ENTA)

10/30/15 8:58 AM

#1175 RE: DewDiligence #1174

Why US docs prefer Harvoni by such a wide margin? Kickback?

US
V-Pak 242 8.7%

EU
V-Pak 227 29.9%

10/30/15 10:16 AM

#1176 RE: DewDiligence #1174

Why no positive rxn in stock price of ENTA? What am I missing?

10/30/15 10:28 AM

#1178 RE: DewDiligence #1174

ABBV’s latest HCV guidance: #msg-118117768.